Associations with pancreatic exocrine insufficiency: An United Kingdom single-centre study

Table 2 Distribution of symptoms in the total cohort and by faecal elastase-1 result, and results from the univariable logistic regression analysis.

Symptom	Total cohort, n (%)	FE1 ≥ 200 μg/g, n (%)	FE1 < 200 μg/g, n (%)	OR (95%CI)	P value
Abdominal pain	567 (55.2)	476 (56.3)	91 (50.0)	0.77 (0.56-1.06)	0.112
Diarrhoea	671 (65.3)	545 (64.5)	126 (69.2)	1.23 (0.87-1.74)	0.231
Weight loss	392 (38.2)	308 (36.4)	84 (46.2)	1.49 (1.08-2.06)	0.015
Bloating	263 (25.6)	226 (26.7)	37 (20.3)	0.70 (0.47-1.03)	0.072
Nausea and vomiting	129 (12.6)	106 (12.5)	23 (12.6)	1.01 (0.62-1.63)	0.973
Steatorrhoea	95 (9.3)	64 (7.6)	31 (17.0)	2.51 (1.58-3.98)	< 0.001
Dyspepsia	86 (8.4)	71 (8.4)	15 (8.2)	0.98 (0.55-1.75)	0.943
Flatulence	61 (5.9)	55 (6.5)	6 (3.3)	0.49 (0.21-1.16)	0.103
Fatigue	21 (2.0)	19 (2.3)	2 (1.1)	0.48 (0.11-2.09)	0.331

FE1: Faecal elastase-1.